HomeMRKR • NASDAQ
Follow
Marker Therapeutics Inc
Previous close
$4.46
Day range
$4.15 - $4.55
Year range
$0.67 - $9.68
Market cap
38.18M USD
Avg Volume
19.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 257.61K | -74.23% |
Operating expense | 1.41M | -56.32% |
Net income | -2.98M | 56.91% |
Net profit margin | -1.16K | -67.22% |
Earnings per share | — | — |
EBITDA | -2.50M | 50.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.47M | -3.33% |
Total assets | 19.49M | -52.60% |
Total liabilities | 2.78M | -84.99% |
Total equity | 16.71M | — |
Shares outstanding | 8.89M | — |
Price to book | 2.37 | — |
Return on assets | -38.61% | — |
Return on capital | -44.77% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -2.98M | 56.91% |
Cash from operations | -1.13M | 85.25% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 479.27K | — |
Net change in cash | -648.19K | 91.63% |
Free cash flow | -145.57K | 97.37% |
About
Founded
1992
Headquarters
Website
Employees
8